Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care
- PMID: 32959201
- PMCID: PMC7736003
- DOI: 10.1007/s12028-020-01085-0
Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care
Abstract
Effective treatment options for patients with life-threatening neurological disorders are limited. To address this unmet need, high-impact translational research is essential for the advancement and development of novel therapeutic approaches in neurocritical care. "The Neurotherapeutics Symposium 2019-Neurological Emergencies" conference, held in Rochester, New York, in June 2019, was designed to accelerate translation of neurocritical care research via transdisciplinary team science and diversity enhancement. Diversity excellence in the neuroscience workforce brings innovative and creative perspectives, and team science broadens the scientific approach by incorporating views from multiple stakeholders. Both are essential components needed to address complex scientific questions. Under represented minorities and women were involved in the organization of the conference and accounted for 30-40% of speakers, moderators, and attendees. Participants represented a diverse group of stakeholders committed to translational research. Topics discussed at the conference included acute ischemic and hemorrhagic strokes, neurogenic respiratory dysregulation, seizures and status epilepticus, brain telemetry, neuroprognostication, disorders of consciousness, and multimodal monitoring. In these proceedings, we summarize the topics covered at the conference and suggest the groundwork for future high-yield research in neurologic emergencies.
Keywords: Conference proceedings; Diversity excellence; Neurocritical care; Team science; Translational research.
Conflict of interest statement
Dr. Simpkins has nothing to disclose; Dr. Busl reports personal fees from Guidepoint Global, personal fees from Techspert, other from American Academy of Neurology, outside the submitted work; Dr. Amorim has nothing to disclose; Dr. Barnett reports grants from Octapharma, grants from Grifols, personal fees from Alexion, personal fees from Takeda, personal fees from Akcea, personal fees from CSL, outside the submitted work; Dr. Cervenka reports grants and personal fees from Nutricia, grants from Vitaflo, grants from BrightFocus Foundation, personal fees from Demos, personal fees from Glut2 Deficiency Foundation, outside the submitted work; Dr. Dhakar reports personal fees from Adamas Pharmaceuticals, outside the submitted work; Dr. Etherton has nothing to disclose; Ms. Fung has nothing to disclose; Dr. Griggs reports grants from Strongbridge Biopharma, grants from Attune Medical, during the conduct of the study; grants from PTC Therapeutics (formerly Marathon Pharma), grants from Sarepta Therapeutics, grants from Foundation to Eradicate Duchenne (FED), grants from Muscular Dystrophy Association (MDA), grants from Parent Project Muscular Dystrophy (PPMD), outside the submitted work; Dr. Holloway has nothing to disclose; Dr. Kelly has nothing to disclose; Dr. Khan has nothing to disclose; Dr. Lizarraga has nothing to disclose; Ms. Madagan has nothing to disclose; Dr. Merck reports grants from NIH, grants from DoD, grants from Bill and Melinda Gates Foundation, outside the submitted work; Dr. Mestre has nothing to disclose; Dr. Rabinstein has nothing to disclose; Dr. Rubinos has nothing to disclose; Dr. Youn has nothing to disclose; Dr. Maciel has nothing to disclose.
References
-
- Fiscella K, Mauksch L, Bodenheimer T, Salas E. Improving care teams’ functioning: recommendations from team science. Jt Comm J Qual Patient Saf. 2017;43:361–368. - PubMed
-
- Marulanda-Londono ET, Bell MW, Hope OA, et al. Reducing neurodisparity: recommendations of the 2017 AAN diversity leadership program. Neurology. 2019;92:274–280. - PubMed
-
- Rosendale N, Ostendorf T, Evans DA, et al. American academy of neurology members’ preparedness to treat sexual and gender minorities. Neurology. 2019;93:159–166. - PubMed
-
- Silver JK. Understanding and addressing gender equity for women in neurology. Neurology. 2019;93:538–549. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
